Skip to Content

202 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint 202 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Torrent Pharmaceuticals Limited.

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 202

Darifenacin Hydrobromide Extended-Release

Imprint
202
Strength
7.5 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Torrent Pharmaceuticals Limited
National Drug Code (NDC)
13668-0202
Inactive Ingredients
microcrystalline cellulose, hypromellose 2208 (4000 mPa.s), hypromellose 2910 (15 mPa.s), magnesium stearate, polyethylene glycol 400, silicon dioxide, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "202"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.